Axsome Therapeutics, Inc.
US ˙ NasdaqGM ˙ US05464T1043

SecurityAXSM / Axsome Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership281,503 shares
Latest Disclosed Value $ 47,579,637
Citadel Advisors Llc ownership in AXSM / Axsome Therapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 281,503 shares of Axsome Therapeutics, Inc. (US:AXSM) valued at $47,579,637 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 138,213 shares of Axsome Therapeutics, Inc.. This represents a change in shares of 103.67% during the quarter. The current value of the position is $65,398,777 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (AXSM) in the form of stock options. The firm currently holds call options representing 104,500 of underlying shares valued at $17,662,590 USD and put options representing 35,000 of underlying shares valued at $5,915,700 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AXSM / Axsome Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AXSOME THERAPEUTICS COM 05464T104 281,503 143,290 103.67 47,580 88.48 0.0077
2026-02-17 2025-12-31 13F AXSOME THERAPEUTICS COM 05464T104 138,213 -20,193 -12.75 25,243 31.21 0.0038
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM 05464T104 158,406 144,788 1,063.21 19,238 1,253.84 0.0029
2025-08-14 2025-06-30 13F AXSOME THERAPEUTICS COM 05464T104 13,618 -70,168 -83.75 1,422 -85.46 0.0002
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM 05464T104 83,786 -411,603 -83.09 9,772 -76.69 0.0019
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM 05464T104 495,389 190,707 62.59 41,915 53.08 0.0073
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM 05464T104 304,682 -448,555 -59.55 27,382 -54.84 0.0053
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM 05464T104 753,237 -390,407 -34.14 60,636 -33.56 0.0123
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM 05464T104 1,143,644 54,559 5.01 91,263 5.29 0.0176
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM 05464T104 1,089,085 -206,539 -15.94 86,680 -4.27 0.0173
2023-11-14 2023-09-30 13F AXSOME THERAPEUTICS COM 05464T104 1,295,624 841,306 185.18 90,551 177.36 0.0194
2023-08-14 2023-06-30 13F AXSOME THERAPEUTICS COM 05464T104 454,318 255,297 128.28 32,647 165.96 0.0067
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM 05464T104 199,021 -164,720 -45.28 12,276 -56.25 0.0027
2023-02-14 2022-12-31 13F AXSOME THERAPEUTICS COM 05464T104 363,741 -167,596 -31.54 28,055 18.34 0.0066
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM 05464T104 531,337 80,342 17.81 23,708 37.25 0.0054
2022-08-15 2022-06-30 13F AXSOME THERAPEUTICS COM 05464T104 450,995 213,982 90.28 17,273 76.08 0.0044
2022-05-16 2022-03-31 13F AXSOME THERAPEUTICS COM 05464T104 237,013 -71,278 -23.12 9,810 -15.77 0.0020
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS COM 05464T104 308,291 224 0.07 11,647 14.70 0.0024
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS Cmn 05464T104 308,067 -261,738 -45.93 10,154 -73.58 0.0021
2021-08-16 2021-06-30 13F AXSOME THERAPEUTICS COM 05464T104 569,805 160,511 39.22 38,439 65.87 0.0086
2021-05-21 2021-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 409,294 -314,845 -43.48 23,174 -60.72 0.0057
2021-05-17 2021-03-31 13F AXSOME THERAPEUTICS COM 05464T104 409,294 -314,845 23,174 0.0057
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS COM 05464T104 724,139 492,133 212.12 58,996 256.90 0.0153
2020-11-16 2020-09-30 13F AXSOME THERAPEUTICS COM 05464T104 232,006 -225,068 -49.24 16,530 -56.05 0.0047
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS Cmn 05464T104 457,074 -306,420 -40.13 37,608 -16.27 0.0134
2020-05-15 2020-03-31 13F AXSOME THERAPEUTICS Cmn 05464T104 763,494 185,851 32.17 44,916 -24.77 0.0202
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS Cmn 05464T104 577,643 453,636 365.81 59,705 2,278.69 0.0259
2019-11-14 2019-09-30 13F AXSOME THERAPEUTICS Cmn 05464T104 124,007 82,473 198.57 2,510 134.58 0.0012
2019-08-14 2019-06-30 13F AXSOME THERAPEUTICS Cmn 05464T104 41,534 8,258 24.82 1,070 125.74 0.0005
2019-05-15 2019-03-31 13F AXSOME THERAPEUTICS Cmn 05464T104 33,276 33,276 -19.88 474 -55.70 0.0002
2018-11-13 2018-09-30 13F AXSOME THERAPEUTICS Cmn 05464T104 0 -15,581 -100.00 0 -100.00
2018-08-14 2018-06-30 13F/A-1 AXSOME THERAPEUTICS Cmn 05464T104 15,581 15,581 50 0.0000
2018-08-10 2018-06-30 13F AXSOME THERAPEUTICS Cmn 05464T104 15,581 15,581 50
2017-02-10 2016-12-31 13F AXSOME THERAPEUTICS Cmn 05464T104 0 -13,171 -100.00 0 -100.00
2017-01-31 2016-09-30 13F/A-1 AXSOME THERAPEUTICS Cmn 05464T104 13,171 13,171 104 0.0001
2016-11-10 2016-09-30 13F AXSOME THERAPEUTICS Cmn 05464T104 13,171 104 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AXSOME THERAPEUTICS COM Call 104,500 -40.62 17,663 -45.05 n/a n/a n/a
2026-02-17 2025-12-31 13F AXSOME THERAPEUTICS COM Call 176,000 94.05 32,145 191.82 n/a n/a n/a
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM Call 90,700 -6.78 11,016 8.45 n/a n/a n/a
2025-08-14 2025-06-30 13F AXSOME THERAPEUTICS COM Call 97,300 -4.70 10,157 -14.70 n/a n/a n/a
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM Call 102,100 -52.78 11,908 -34.91 n/a n/a n/a
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM Call 216,200 55.76 18,293 46.65 n/a n/a n/a
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM Call 138,800 70.31 12,474 90.14 n/a n/a n/a
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM Call 81,500 6.68 6,561 7.61 n/a n/a n/a
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM Call 76,400 -31.11 6,097 -30.93 n/a n/a n/a
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM Call 110,900 35.74 8,827 54.57 n/a n/a n/a
2023-11-14 2023-09-30 13F AXSOME THERAPEUTICS COM Call 81,700 -67.06 5,710 -67.96 n/a n/a n/a
2023-08-14 2023-06-30 13F AXSOME THERAPEUTICS COM Call 248,000 60.21 17,821 86.65 n/a n/a n/a
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM Call 154,800 -68.04 9,548 -74.44 n/a n/a n/a
2023-02-14 2022-12-31 13F AXSOME THERAPEUTICS COM Call 484,400 -19.60 37,362 38.97 n/a n/a n/a
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM Call 602,500 -0.77 26,884 15.60 n/a n/a n/a
2022-08-15 2022-06-30 13F AXSOME THERAPEUTICS COM Call 607,200 -22.20 23,256 -28.01 n/a n/a n/a
2022-05-16 2022-03-31 13F AXSOME THERAPEUTICS COM Call 780,500 -16.30 32,305 -8.30 n/a n/a n/a
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS COM Call 932,500 103.42 35,230 133.17 n/a n/a n/a
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS Cmn Call 458,400 170.60 15,109 32.21 n/a n/a n/a
2021-08-16 2021-06-30 13F AXSOME THERAPEUTICS COM Call 169,400 92.94 11,428 129.89 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AXSOME THERAPEUTICS COM Call 87,800 -28.68 4,971 -50.43 n/a n/a n/a
2021-05-17 2021-03-31 13F AXSOME THERAPEUTICS COM Call 87,800 4,971 n/a n/a n/a
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS COM Call 123,100 -24.94 10,029 -14.17 n/a n/a n/a
2020-11-16 2020-09-30 13F AXSOME THERAPEUTICS COM Call 164,000 5.06 11,685 -9.02 n/a n/a n/a
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS Cmn Call 156,100 -58.91 12,844 -42.53 n/a n/a n/a
2020-05-15 2020-03-31 13F AXSOME THERAPEUTICS Cmn Call 379,900 27.91 22,350 -27.19 n/a n/a n/a
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS Cmn Call 297,000 111.99 30,698 982.44 n/a n/a n/a
2019-11-14 2019-09-30 13F AXSOME THERAPEUTICS Cmn Call 140,100 55.32 2,836 22.08 n/a n/a n/a
2019-08-14 2019-06-30 13F AXSOME THERAPEUTICS Cmn Call 90,200 108.80 2,323 277.72 n/a n/a n/a
2019-05-15 2019-03-31 13F AXSOME THERAPEUTICS Cmn Call 43,200 615 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AXSOME THERAPEUTICS COM Put 35,000 -56.14 5,916 -59.41 n/a n/a n/a
2026-02-17 2025-12-31 13F AXSOME THERAPEUTICS COM Put 79,800 -24.65 14,575 13.32 n/a n/a n/a
2025-11-14 2025-09-30 13F AXSOME THERAPEUTICS COM Put 105,900 3.32 12,862 20.21 n/a n/a n/a
2025-08-14 2025-06-30 13F AXSOME THERAPEUTICS COM Put 102,500 10.33 10,700 -1.25 n/a n/a n/a
2025-05-15 2025-03-31 13F AXSOME THERAPEUTICS COM Put 92,900 -24.78 10,835 3.68 n/a n/a n/a
2025-02-14 2024-12-31 13F AXSOME THERAPEUTICS COM Put 123,500 52.85 10,449 43.91 n/a n/a n/a
2024-11-14 2024-09-30 13F AXSOME THERAPEUTICS COM Put 80,800 8.31 7,261 20.92 n/a n/a n/a
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM Put 74,600 -9.79 6,005 -9.00 n/a n/a n/a
2024-05-15 2024-03-31 13F AXSOME THERAPEUTICS COM Put 82,700 -8.82 6,599 -8.58 n/a n/a n/a
2024-02-14 2023-12-31 13F AXSOME THERAPEUTICS COM Put 90,700 -3.41 7,219 10.00 n/a n/a n/a
2023-11-14 2023-09-30 13F AXSOME THERAPEUTICS COM Put 93,900 -34.61 6,563 -36.41 n/a n/a n/a
2023-08-14 2023-06-30 13F AXSOME THERAPEUTICS COM Put 143,600 -32.17 10,319 -20.97 n/a n/a n/a
2023-05-15 2023-03-31 13F AXSOME THERAPEUTICS COM Put 211,700 -69.30 13,058 -75.45 n/a n/a n/a
2023-02-14 2022-12-31 13F AXSOME THERAPEUTICS COM Put 689,600 -17.29 53,189 42.96 n/a n/a n/a
2022-11-14 2022-09-30 13F AXSOME THERAPEUTICS COM Put 833,800 95.59 37,204 127.87 n/a n/a n/a
2022-08-15 2022-06-30 13F AXSOME THERAPEUTICS COM Put 426,300 185.72 16,327 164.40 n/a n/a n/a
2022-05-16 2022-03-31 13F AXSOME THERAPEUTICS COM Put 149,200 -46.70 6,175 -41.61 n/a n/a n/a
2022-02-14 2021-12-31 13F AXSOME THERAPEUTICS COM Put 279,900 -38.24 10,575 -29.20 n/a n/a n/a
2021-11-15 2021-09-30 13F AXSOME THERAPEUTICS Cmn Put 453,200 128.89 14,937 11.83 n/a n/a n/a
2021-08-16 2021-06-30 13F AXSOME THERAPEUTICS COM Put 198,000 -4.35 13,357 13.97 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AXSOME THERAPEUTICS COM Put 207,000 26.99 11,720 -11.75 n/a n/a n/a
2021-05-17 2021-03-31 13F AXSOME THERAPEUTICS COM Put 207,000 11,720 n/a n/a n/a
2021-02-16 2020-12-31 13F AXSOME THERAPEUTICS COM Put 163,000 0.49 13,280 14.91 n/a n/a n/a
2020-11-16 2020-09-30 13F AXSOME THERAPEUTICS COM Put 162,200 28.63 11,557 11.38 n/a n/a n/a
2020-08-14 2020-06-30 13F AXSOME THERAPEUTICS Cmn Put 126,100 -17.90 10,376 14.83 n/a n/a n/a
2020-05-15 2020-03-31 13F AXSOME THERAPEUTICS Cmn Put 153,600 -9.11 9,036 -48.27 n/a n/a n/a
2020-02-14 2019-12-31 13F AXSOME THERAPEUTICS Cmn Put 169,000 116.67 17,468 1,006.27 n/a n/a n/a
2019-11-14 2019-09-30 13F AXSOME THERAPEUTICS Cmn Put 78,000 167.12 1,579 109.97 n/a n/a n/a
2019-08-14 2019-06-30 13F AXSOME THERAPEUTICS Cmn Put 29,200 -48.77 752 -7.27 n/a n/a n/a
2019-05-15 2019-03-31 13F AXSOME THERAPEUTICS Cmn Put 57,000 811 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.